drugset / Trial / NCT02401230

PrEP, Lube, and the Rectal Mucosa in MSM at Risk of HIV

NCT02401230

RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to determine whether the use of rectal lubricants can affect how well the medication, Truvada, will work to prevent infection with HIV when someone is exposed to HIV in the rectum.

Timeline

Start
2015-03
Primary completion
2017-01-25
Completion
2017-01-25

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tenofovir disoproxil fumarate Small molecule 300 mg Oral
Comparator emtricitabine Other / unclassified 200 mg Oral